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Abstract  
Objective: To determine the association between anxiety during critical illness and 
symptoms of anxiety and depression over six months after ICU discharge in survivors 
of intensive care treatment. 
Design: Longitudinal study.  
Setting: One closed mixed ICU in an adult tertiary hospital in Brisbane, Australia. 
Patients: Participants (n=141) were adults (≥18 years), admitted to ICU for ≥24 
hours, able to communicate either verbally or non-verbally, understand English, and 
open their eyes spontaneously or in response to voice. 
Interventions: None. 
Measurements and Main Results: The outcomes of symptoms of anxiety and 
depression over six months after ICU discharge were assessed using the Hospital 
Anxiety Depression Scale. The primary variable of interest was anxiety during critical 
illness. Two components of anxiety (state and trait) were assessed during critical 
illness using the Faces Anxiety Scale and the trait component of the State-Trait 
Anxiety Inventory. Perceived social support, cognitive functioning and post-traumatic 
stress symptoms were also assessed using standardised instruments. Clinical and 
demographic data were obtained from patients and medical records. Participants were 
followed-up in hospital wards, and at three and six months after ICU discharge. 
During ICU treatment, 81 (57%) of the 141 participants reported moderate to 
severe levels of state anxiety. Of the 92 participants who completed the surveys at the 
six-month follow-up, 26 (28%) reported symptoms of anxiety and 21 (23%) 
symptoms of depression. Symptoms of anxiety and depression were strongly 
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correlated in this cohort of survivors. Trait anxiety was significantly associated with 
both anxiety and depression symptoms over time, however, state anxiety was not 
associated with either outcome. Participants who reported post-ICU memories of 
intra-ICU anxiety were significantly more anxious during recovery over six months. 
Cognitive functioning and post-traumatic stress symptoms were both significantly 
associated with anxiety and depression symptoms over time. 
Conclusion: Symptoms of anxiety and depression are a significant issue for general 
ICU survivors. Trait anxiety was significantly associated with adverse emotional 
outcomes over six months after ICU discharge. There was also a significant 
relationship between post-ICU memories of intra-ICU anxiety and anxiety during 
recovery. Interventions to reduce anxiety during critical illness need to be considered 
and evaluated for their longer term benefits for survivors of critical illness. 
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Introduction  
Survival from critical illness has improved significantly over the years with most 
patients discharged alive from hospital. For some survivors however, the recovery 
process can be physically and emotionally challenging. Numerous observational studies 
have reported on the emotional problems, including symptoms of anxiety and 
depression, that patients experience after critical illness. The prevalence of these 
emotional problems in intensive care unit (ICU) survivors is relatively high with around 
a third of patients reporting adverse emotional outcomes (1-5). 
The widespread nature of this problem has led researchers to explore factors 
associated with adverse emotional outcomes (6, 7). Anxiety during critical illness has 
repeatedly been suggested as important (6, 8, 9). Anxiety is a complex phenomenon that 
comprises of two components: state and trait (10, 11). State anxiety is defined as a 
normal and temporary emotion that involves physiological arousal and feelings of 
tension, apprehension, nervousness and worry when a stressful situation is perceived. 
Trait anxiety, on the other hand, corresponds to a person's tendency to become state 
anxious as part of their personality trait (10, 11). To achieve a comprehensive 
understanding of anxiety during critical illness in our cohort of survivors, both 
components of anxiety (state and trait) were explored. We hypothesised that state and 
trait anxiety would be associated with anxiety and depression symptoms over time after 
ICU discharge. 
The aim of this study was to determine the association between anxiety during 
critical illness (state and trait) and symptoms of anxiety and depression in survivors of 
critical illness over six months post ICU discharge.   
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Materials and Methods 
This longitudinal cohort study of general ICU survivors was conducted in one 
closed mixed medical/surgical/trauma ICU of a tertiary metropolitan public hospital 
located in Brisbane, Australia. The Intensive Care Unit has 25 beds and provides 24 
hours intensivist led care with a registered nurse-patient ratio of 1:1. During the time of 
enrolment (September 2012−February 2013) there were approximately 1,100 
admissions to this ICU. The Princess Alexandra Hospital (HREC/12/QPAH/173) and 
Griffith University (NRS/35/12/HREC) Ethics Committees approved this research. All 
participants provided written informed consent. The study protocol has previously been 
published (12). However, a summary of the methods and modifications made to the 
published protocol are provided in this section.  
Patients 
Participants were adults (≥18 years), admitted to the ICU for ≥24 hours, able to 
communicate either verbally or non-verbally (pointing, gestures, written, mouthing, 
etc.), understand English, and open their eyes spontaneously or in response to voice 
(visually intact or sufficient corrected vision). 
Data Collection  
Study participants provided information in ICU, in the hospital wards, and at 
three and six months post ICU discharge. Participants were followed-up in the hospital 
wards (within three weeks of ICU discharge) to confirm their wish to participate in this 
study, obtain written informed consent and complete the first set of self-reported 
questionnaires (Table 1). At three and six-month follow-up participants were contacted 
by a phone call to remind them about their involvement in this study before posting the 
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surveys. An appointment for a phone interview was scheduled for those participants 
who wished to provide the answers to the researcher over the phone. Most participants 
returned the surveys in the reply paid envelope provided, twelve participants read their 
answers to the researcher over the phone, and two participants preferred to use email. 
State anxiety was assessed twice a day (morning 8-11am and afternoon 4-7pm) 
up to 30 days during ICU stay. These timeframes were selected to identify any 
difference between morning assessments (usually busier ICU environment) and evening 
assessments (usually quieter ICU environment). Patient’s competency to report on their 
level of state anxiety was determined by consultation with the bedside registered nurse 
and patient’s ability to communicate effectively (verbally or not verbally) with the 
researchers.  
The assessment of trait anxiety was performed once only when participants were 
in the wards for two reasons: [1] The State-Trait Anxiety Inventory (STAI) Form Y-2 is 
a 20-Item instrument, with completion requiring a patient to be able to maintain 
attention for about 10 minutes. [2] Trait personalities are stable patterns of cognition, 
affective reactions and behavior that are relatively consistent across time and situations 
(13). Thus, trait anxiety would have been unlikely to change in such a short period 
(between ICU stay and assessment in the wards). The principal investigator and the ICU 
Research Nurse conducted the state anxiety assessments in ICU and assisted the 
participants (when needed due to physical impairment) with the surveys in hospital 
wards. 
Clinical and demographic data collected from medical records included: age, 
gender, type of admission (medical, surgical, trauma, cardiac surgery), delirium 
(Confusion Assessment Method – ICU: CAM-ICU), hours of mechanical ventilation 
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(invasive and non-invasive), acute physiology and chronic health evaluation III score 
(APACHE III), length of ICU stay (days), length of hospital stay (days) and pain using 
the Critical-Care Pain Observation Tool (CPOT) (14-17). Data on drugs administered 
included exposure to corticosteroids, opioids, benzodiazepines, anxiolytics, 
antidepressants, beta-blockers, anesthetic agents and analgesics; length of sedation and 
analgesia (hours of propofol, midazolam, morphine, fentanyl, ketamine, oxycodone 
infusion); and total doses of sedatives and analgesics (propofol, midazolam, morphine, 
fentanyl, ketamine, oxycodone and paracetamol).  
Data collected in the hospital wards using a questionnaire included: marital 
status, employment status and level of education, pre-ICU medications 
(benzodiazepines, anxiolytics, antidepressants, corticoids, opioids, and beta-blockers), 
smoking status and evidence of mental health treatment. Participants who answered 
“Yes” to either of the following two question was considered to have evidence of 
mental health treatment prior to the ICU admission: [1] Have you ever visited a general 
practitioner or a mental health professional for symptoms of psychological distress or 
emotional problems? [2] Were you taking benzodiazepines, anxiolytics or 
antidepressants medications within the 12 months prior to the ICU admission? Mental 
health history was assessed using this approach to capture any indication of mental 
health problems prior to the ICU admission more thoroughly than was likely if relying 
on mental health history from medical records. A similar approach has previously been 
used in a cohort of ICU patients (18). The demographic questionnaire is provided as 
Supplementary Material 1. 
Instruments used in this study are outlined in Table 1 and included: the Post-
traumatic Stress Symptoms 10-Question Inventory (PTSS-10), trait component of the 
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State-Trait Anxiety Inventory (STAI) for Adults Form Y-2, Hospital Anxiety and 
Depression Scale (HADS), Faces Anxiety Scale (FAS), Multidimensional Scale of 
Perceived Social Support (MSPSS), Life Orientation Test-Revised (LOT-R) and 
Cognitive Functioning Scale Medical Outcome Study 6-Item (MOS COG). These tools 
were chosen because they are self-reported, well validated and easy to understand 
instruments, take a few minutes to complete, and with the exception of Cognitive 
Functioning Scale Medical Outcome Study 6-Item (MOS COG), have all been used in 
ICU research (11, 19-24). 
Information about pre-ICU medications, social support, cognitive functioning, 
trait optimism and post-traumatic stress symptom (PTSS) were collected because the 
literature suggests a possible association between these factors and adverse emotional 
outcomes after ICU (25-28). 
Data analysis 
Power analysis a priori using G*Power was performed to estimate the sample 
size of this study (29). Multiple regression test (fixed model, R2 increase) with a power 
of 80%, a significance level of α=0.05 and a medium size effect (0.15) were selected. 
The effect size was estimated from previous research exploring similar research 
questions (30, 31). In addition, we expected a maximum of seven variables to be 
included in the final model, a mortality rate of 10% and a dropout of 30% at six months. 
Thus, it was estimated that we needed 104 participants at six months follow up.  
Stata version 13 (Statacorp, College Station, Texas) was used for all analysis 
(32). Data were cleaned and checked for missing, invalid and outlying values. A random 
selection (15%) of the database was verified against original questionnaires. Categorical 
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data were reported as percentages and continuous data as means and standard deviations 
(SDs) or medians and interquartile ranges (IQRs). Comparisons of the characteristics of 
responders and non-responders were made using Chi-square or Fisher’s exact test, t-test 
for differences in means, and nonparametric tests for rank differences. 
The independent variable “state anxiety” was derived from repeated measures 
taken during the participants ICU stay (twice a day up to 30 days). The first state 
anxiety measure in ICU and several aggregate variables were extensively explored to 
obtain a single value that best represented the level of state anxiety during the patient’s 
ICU stay. Of all derived (aggregated) measures for anxiety, the mean value was the 
strongest at accounting for correlations amongst observations in the same cluster. 
Participants were categorised as low anxious (state anxiety mean score 1-2) and 
moderate to severe anxious (state anxiety mean score 3-5) (21). 
Variables associated with the outcome (p<0.20) on bivariate analysis were 
selected for models. Selected variables were checked against one another for 
multicollinearity using Spearman correlations and Chi-square. After this process, 
variables were ranked from most to the least significant and entered into the model. 
Mixed effect regression models with a random intercept per subject were used to assess 
the independent association of each factor with symptoms of anxiety and depression 
while accounting for repeated data from the same participants. Mixed model analysis is 
used in longitudinal studies to adjust for dependency of repeated observations (account 
for correlated observations within one subject over time). Time is explicit with 
observations over time nested within subject (33). In other words, all data from 
measures obtained serially such as cognitive functioning, PTSS and social support were 
included in the mixed model analysis and adjusted for dependency over time. Mixed 
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models also better handle missing data by using available data from all subjects 
regardless of whether their data are complete. 
The Akaike Information Criteria (AIC) along with statistical significance (p<0.05) were 
used to identify the best set of variables significantly and independently associated with 
adverse emotional outcomes (symptoms of anxiety and depression). Theory-grounded 
factors were added into the ‘final set’ of variables to check whether they influenced the 
model (i.e. were significant and/or decreased/improved the AIC). Potential interaction 
effects were assessed using the likelihood ratio test (LR), comparing the final anxiety 
and depression models (with no interaction term) against models with one interaction 
term at a time. The importance of interaction effects were based on the results of LR 
test, where P>0.05 indicated a non-significant interaction. The potential impact of 
missing data was investigated using a descriptive approach, comparing the baseline data 
of responders and non-responders from subsequent follow-up points.  
Model results are expressed as unstandardized coefficients, 95% confidence 
intervals and p-values. Model diagnostics included assessment of influential 
observations, multicollinearity amongst variables and residual checks.  
Results 
In total 797 patients were screened with 141 enrolled between September 2012 
and February 2013. From 141 participants enrolled, 120 consented to participate in the 
follow-up. One hundred and one (84%) participants completed three-month follow-up 
and 92 (77%) completed six-month follow-up (Figure 1). Participants were a mixed 
medical (49%), surgical (34%) and trauma (17%) group of ICU patients with an average 
age of 54 (standard deviation, SD±15) years, and 70% were male. The median length of 
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ICU stay and hospital stay were 4 [interquartile range, IQR: 3-7] days and 15 [10-28] 
days, respectively. The majority of participants required invasive mechanical ventilation 
(82%) for about 52 [13-148] hours, and the median APACHE III score of this sample 
was 58 [43-74].  
Symptoms of anxiety (HADS≥8) were reported by 42% of the participants while 
in the hospital wards, 26% at three-month and 28% at six-month follow-up. Symptoms 
of depression (HADS≥8) were reported by 37% of the participants while in hospital 
wards, 19% at three-month and 23% at six-month follow-up. Symptoms of anxiety 
decreased significantly from hospital to assessment at three-month after ICU discharge 
(7.0 [4.0-10.0] vs. 5.0 [2.5–8.0], p<0.001). Symptoms of depression also decreased 
significantly over the same period (5.5 [3.0–9.0] vs. 3.0 [2.0 – 6.0], p<0.001). No 
significant change was observed from three to six-month follow-up on either symptoms 
of anxiety or depression. Participants moved between categories 
(symptomatic/asymptomatic) of anxiety and depression over time. Some participants 
who scored within normal limits (HADS<8) in the wards presented with symptoms of 
emotional distress at three and or six months and vice versa (Figures 2 and 3). 
Most participants (82%) reported state anxiety in ICU, with 57% reporting 
moderate to severe levels (FAS 3-5). When considering the 604 individual anxiety 
assessments, participants reported some level of anxiety 393 (65%) of the time, with 
173 (44%) of these being moderate to severe levels. While the levels of state anxiety 
fluctuated over time, there was no significant difference between morning and afternoon 
assessments.  
The levels of trait anxiety in the study participants were very similar to the 
Australian population (36.0 [29.0-47.0]) (34). The mean trait optimism (14.7, SD±4.2) 
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was also similar to population-base norms and another cohort of ICU patients (5, 35). 
Delirium was present in 11 (8%) participants and pain in 65 (46%) participants. The 
most common sedatives and analgesics administered were propofol (84%), fentanyl 
(79%), midazolam (35%) and morphine (26%). Other demographic information and 
data about medications administered during ICU treatment are presented in Table 2.  
Perceived levels of social support did not change from three months to six 
months post ICU discharge (6.0 [5.3-6.6] vs. 6.0 [5.0-6.5] p=0.088) and they were 
similar to the ones reported in other populations (22). On the contrary, perceived 
cognitive functioning increased significantly from hospital to assessment at three 
months after ICU discharge (56.7 [40.8-70.0] vs. 63.0 [57.0-77.0] p<0.001). No 
significant increase was observed from three to six months. Despite the initial increase 
in perceived cognitive functioning, these levels are well below population-based norms 
(24). Approximately 58-76% of participants reported traumatic memories of their ICU 
admission at each of the follow-up points. Changes in the proportion of participants 
who presented with traumatic memories of the ICU admission across the three-time 
points measured (in the wards, three and six months after ICU discharge) are presented 
in Supplementary Material 2. The prevalence of PTSS was similar at three and six 
months (n=19, 19% vs. n=15, 17%).  
Participants who completed six-month follow-up were similar to non-responders 
in gender, length of ICU stay, length of hospital stay and APACHE III score. Non-
responders were younger and reported higher levels of anxiety (state and trait) in 
hospital than the responders (Table 3). These differences were similar at three and six-
month follow-up. 
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Linear mixed effect models showed a decline in anxiety symptoms over six 
months after ICU discharge. The most significant drop occurred from ICU to three 
months (β=-0.8, 95% CI -1.5, -0.1, p<0.02). Trait anxiety, symptoms of depression 
during recovery, self-reported cognitive functioning, memories of anxiety in ICU, 
evidence of mental health treatment prior to the ICU admission and six month PTSS 
score were all significantly associated with symptoms of anxiety over six months after 
ICU discharge (Table 4). Symptoms of depression decreased over the six months after 
ICU discharge. Symptoms of anxiety during recovery, trait anxiety, self-reported 
cognitive functioning and reason for ICU admission (trauma patients) were all 
significantly associated with symptoms of depression over the six months after ICU 
discharge (Table 5). 
The likelihood- ratio test established no significant interaction effects in the final 
anxiety and depression models. Descriptive analyses of missing data showed non-
responders at three months follow-up reported higher baseline anxiety and depression 
scores than responders. These differences were no longer significant at six months. 
Non-responders at three and six months reported higher trait anxiety levels, more 
evidence of mental health treatment prior to ICU admission and more post-ICU 
memories of anxiety than responders at the baseline.  
Discussion 
In this study, we identified factors associated with symptoms of anxiety and 
depression over six months after intensive care treatment in survivors of critical illness. 
The role of anxiety during critical illness on adverse emotional outcomes during 
recovery was the primary focus of this study.  
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Symptoms of anxiety and depression decreased significantly from the period in 
hospital to three months after discharge with no further significant change from three to 
six months after ICU discharge. These findings are in line with those reported recently 
in a nonsurgical cohort of critically ill patients (36). Anxiety and depression symptoms 
were present in around a quarter of our study participants at six months, numbers that 
were similar to those found in other studies (3, 4, 6, 31, 37). Some participants in this 
cohort moved between asymptomatic and symptomatic categories over time. These 
changes showed that symptoms of emotional distress had a delayed onset in some 
participants, resolved rapidly in others and appeared at varied stages during recovery. 
Ongoing health issues may be one potential explanation for the delayed onset of these 
symptoms. 
The majority of participants reported some degree of state anxiety while in ICU 
with over half of these reporting moderate to severe levels. These findings are in line 
with the current understanding of state anxiety in ICU and highlight the need to improve 
the assessment and management of this symptom in the ICU setting (21).  
Mixed effect regression models revealed that common factors associated with 
symptoms of both anxiety and depression over six months after ICU discharge in our 
sample were trait anxiety, cognitive impairment and PTSS. Trait anxiety showed a clear 
association with symptoms of anxiety and depression; to our knowledge no previous 
study has reported this association. Impaired cognition has previously been associated 
with anxiety and depression symptoms in critical illness survivors (38-41). 
PTSS were associated with both anxiety and depression, however these 
associations appeared to be significant at varying time points. PTSS at three months 
were associated with depression and PTSS at six months with anxiety. These variations 
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also suggest that interventions need to be tailored to individual patients because their 
need for support is likely to change over time.  
Symptoms of depression and anxiety were correlated with each other. While no 
study testing this relationship in the ICU population was located, anxiety and depression 
disorders are often comorbid with each other (42, 43). A recent large multicentre cohort 
study found the majority of the critical care participants who experienced PTSS also had 
depression symptoms (44). It is not surprising in our study therefore to have found a 
relationship between symptoms of anxiety and depression and post-traumatic stress. 
Factors associated exclusively with anxiety symptoms over time were post-ICU 
memories of anxiety during ICU treatment and evidence of mental health treatment 
prior to ICU admission. Only the recall of extremely stressful ICU experiences had 
previously been identified as a factor for anxiety symptoms during recovery (45). 
Patients with mental health history are commonly excluded from studies in this field to 
reduce bias when assessing emotional outcomes after ICU discharge. In this study, we 
chose to include participants who had evidence of mental health treatment prior to the 
ICU admission and in this cohort this history appears to be an important risk factor. 
Collecting information about mental health treatment (history and medications) prior to 
ICU allowed us to identify a negative association between symptoms of anxiety and 
previous mental health treatment. The continuation of usual treatment received by these 
participants might have reduced the burden of anxiety symptoms after the intensive care 
experience but we did not specifically measure ongoing treatment (6, 46). Evidence of 
mental health treatment was not significantly associated with symptoms of depression in 
the multivariate analysis. The meaning of this lack of association is unclear.  
The only factor associated exclusively with depression symptoms was ICU 
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admission due to trauma. With the design used in this study, it is not possible to 
distinguish between the effects of the initial trauma and the effects of the health care 
such as ICU treatment on depression during recovery.  
As mentioned previously, only the trait component of anxiety was associated 
with symptoms of anxiety and depression during recovery, the state component was not 
associated with either outcome. While there was a moderate correlation between state 
and trait anxiety, state anxiety did not appear to have any long-term effect on adverse 
emotional outcomes. This finding was unexpected since we had thought that state 
anxiety was a hidden factor for symptoms of anxiety and depression after ICU. This 
rationale was based on the fact that sedation is often regarded as a predictor of adverse 
emotional outcomes, but with unclear mechanisms for this association. This uncertainty 
raised the idea that high levels of state anxiety in ICU might have been a key factor in 
this relationship (6, 8, 9). Although state anxiety was not a significant factor for anxiety 
and depression symptoms, the recall of being anxious in ICU was significantly 
associated with anxiety symptoms over six months after discharge in our participants 
(45). 
A number of studies in this area have incorporated follow-up of patients at 
varying time points during recovery. However some of these studies have not 
sufficiently adjusted for dependency of observations over time in their analyses or used 
techniques that deal with missing values such as mixed model analysis. This has 
potentially led to results not fully capturing the dynamic nature of the recovery process 
of these patients. In the present study we adopted statistical techniques that model the 
sources of variation and correlation that arise in longitudinal data sets with multiple 
missing data points. Mixed model analysis deals with missing values in such a way that 
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missing scores have no effect on other scores from the same patient. In addition, it 
includes all data available, not only those cases with complete information. 
Potential limitations of this study need to be noted. In this longitudinal study, we 
identified factors associated with symptoms of anxiety and depression, but this study 
was not designed to test any causal relationships. In addition, although we assessed 
symptomatology of adverse emotional outcomes using validated tools, clinical 
diagnoses of anxiety, depression and post-traumatic stress were not made. While we 
measured numerous factors previously identified in the literature, it is possible that 
factors other than those measured here may have influenced the outcomes. The sample 
size was small, however it represented the Australian ICU population well and was 
comparable to other studies in this area (1, 6, 21). Although follow-up rates at three and 
six months were good, the trend for participants lost to follow-up to be younger and 
more likely to suffer from higher anxiety levels (state and trait) may have resulted in 
bias. Participants self-reported cognitive functioning by using the MOS 6-Item 
Cognitive Functioning Scale, this instrument needs further validation in ICU survivors. 
Although traumatic memories of anxiety were significantly associated with anxiety 
symptoms over time, these memories might have been biased by ongoing or current 
anxiety. While trait anxiety was assessed in hospital, trait anxiety may not represent a 
factor associated with critical illness, but participant’s individual personality 
characteristics. It is worth noting that the levels of trait anxiety found in this sample 
were similar to the general Australian population suggesting that critical illness 
survivors with high anxiety personality trait may be at greater risk of developing anxiety 
and depression. Evident descriptive differences in responders and non-responders in 
terms of trait anxiety levels, evidence of mental health treatment prior to ICU admission 
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and post-ICU memories of anxiety could potentially influence model estimates by 
underestimating or overestimating the effect sizes. Further, multiple imputations to 
assess the possibility that the produced estimates might be biased due to missingness 
were not performed.  
This study adds to the body of research assessing long-term recovery from 
critical illness, specifically factors related to emotional problems such as anxiety and 
depression in ICU survivors. Incorporation of these findings into the development and 
implementation of relevant interventions in acute and post-acute settings has the 
potential to reduce adverse emotional outcomes in ICU survivors. This research adds to 
the current literature identifying anxiety and depression symptoms as an important 
problem for survivors of critical illness and that early detection of these symptoms 
might be beneficial for long-term recovery. 
Conclusions  
Findings of this research highlight the ongoing adverse emotional outcomes in 
survivors of critical illness as well as the need for the development and implementation 
of strategies to reduce these symptoms. Because of the long-term effects of critical 
illness and the delayed onset of symptoms in some patients, not only should these 
interventions take place during intensive care treatment but also at different time points 
after ICU discharge. Interventions to address anxiety during critical illness should be 
directed to target both the state and trait components.  
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Figure 1. Longitudinal cohort study of general ICU survivors. Study flow chart 
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 Figure 2. Anxiety scores of survivors of critical illness over the 6 months following ICU discharge 
Participants who reported on the Hospital Anxiety and Depression Scale-Anxiety Subscale (HADS-A) at all time points were included in this diagram 
(n=89). Participants with missing data on the HADS-A at any time point measurement (n=31) were not included. HADS-A score<8 = asymptomatic, 
HADS-A score ≥8 = symptomatic.  
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 Figure 3. Depression scores of survivors of critical illness over the 6 months following ICU discharge 
Participants who reported on the Hospital Anxiety and Depression Scale-Depression Subscale (HADS-D) at all time points were included in this 
diagram (n=89). Participants with missing data on the HADS-D at any time point measurement (n=31) were not included. HADS-D score<8 = 
asymptomatic, HADS-D score ≥8 = symptomatic. 
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Table 1. Study constructs, instruments and data collection schedule 
Construct Instrument Number of items Possible score Measurement time 
points 
Comments 
State anxiety Faces Anxiety 
Scale (FAS) 
1 1-5 In ICU  
Twice a day (morning 8-
11 and afternoon 4-7)  
Each of the five faces of this tool represents a 
different level of anxiety ranging from no anxiety 
(1) to extreme anxiety (5). Patients were shown 
the FAS and asked to rate their levels of anxiety 
by indicating the face that better represented 
how much anxiety they felt at the moment of 
assessment.  
Trait anxiety  Trait component of 
the State-Trait 
Anxiety Inventory 
(STAI) for Adults 
Form Y-2 
20 For each item, a rating 
score between 1 and 4 
is possible. 
 
Total score 20-80 
Hospital wards within 
three weeks after ICU 
discharge 
Higher scores indicate greater levels of trait 
anxiety. 
 
Trait Optimism Life Orientation 
Test-Revised  
(LOT-R) 
10 For each item, a rating 
score between 0 and 4 
is possible. 
 
Total score 0-24 
Hospital wards within 
three weeks after ICU 
discharge 
6 items concerning general expectations relative 
to positive or negative consequences.  
4 filler items not used in the scoring.  
Higher scores indicate greater optimism. 
Symptoms of 
anxiety and 
depression 
 
Hospital Anxiety 
and Depression 
Scale (HADS) 
This tool has two 
subscales 
Depression: 7 
items 
Anxiety: 7 items 
Total: 14 items 
For each item, a rating 
score between 0 and 3 
is possible. 
Total score for each 
subscale 0-21 
Hospital wards within 
three weeks after ICU 
discharge and at three 
and six-month follow-
ups 
 The total score for each subscale can be 
classified into four categories: normal (0-7), mild 
(8-10), moderate (11-14) and severe (15-21).  
Social support  Multidimensional 
Scale of Perceived 
Social Support 
(MSPSS) 
12 For each item a rating 
score between 1 (very 
strongly disagree) and 7 
(very strongly agree) is 
possible. 
Total score 12-84 
Three and six-month 
follow-ups 
Three subscales: family, friends and significant 
other. Higher scores indicated higher levels of 
perceived social support.  
Self-perceived 
cognitive 
 Cognitive 
Functioning Scale 
6 Each item is scored from 
1 (all the time) to 6 
Hospital wards within 
three weeks after ICU 
Self-reported cognitive functioning. This tool 
contains questions assessing areas of memory, 
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functioning  
 
Medical Outcome 
Study 6-Item (MOS 
COG) 
(none of the time). 
Summing the individual 
item scores and 
transforming the 
resulting score to a 0-
100 scale calculate the 
total score. 
discharge and at three 
and six-month follow-
ups 
attention and reasoning. Higher scores indicate 
better cognitive functioning.  
 
Posttraumatic 
Stress Symptoms 
and traumatic 
memories of the 
ICU experience 
 
Posttraumatic 
Stress Symptoms 
10-Question 
Inventory (PTSS-
10) 
This tool has two 
parts 
Part A: 4 
memories 
Part B: 10 
symptoms 
Part A: for each 
memory, a Yes 
(presence of memory) or 
No (absence of memory) 
answer can be selected. 
 
Part B: for each 
symptom, a rating score 
between 1 (never) and 7 
(always) were possible. 
Total score 10 to 70  
Part A: Hospital wards 
within three weeks after 
ICU discharge and at 
three and six-month 
follow-ups 
 
Part B: Three and six-
month follow-ups 
This questionnaire has two-parts (part A and B). 
Part A consists of four traumatic memories of 
their ICU stay (memories of nightmares, severe 
anxiety or panic; severe pain; and feelings of 
suffocation). In part B, the presence and 
intensity of 10 posttraumatic symptoms are 
assessed. Total score can be classified into two 
categories: high probability of PTSD (total score 
≥ 35 points) and low probability of PTSD (< 35 
points). 
 
FAS = Faces Anxiety Scale, PTSD = Posttraumatic Stress Disorder
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Table 2. Demographic and clinical characteristics 
 Variable Frequency (%) 
n=120 
Marital status  
Married/De facto 
Never married 
Separated/Divorced 
Widowed 
 
 
73 (61) 
24 (20) 
19 (16) 
4 (3) 
Level of education  
Primary/secondary school (years 8-10) 
Secondary school (years 11,12) 
Trade/vocational/Diploma 
University 
 
47 (39) 
26 (22) 
26 (22) 
21(17) 
 
Employment status  
Full time work 
Part time/casual  
Retired  
Student/other  
Disability benefit  
Unemployed     
 
 
49 (41) 
19 (16) 
25 (21) 
4 (3) 
18 (15) 
5 (4) 
Smoking status  
Yes 
No 
 
 
33 (28) 
87 (72) 
 
Evidence of mental health treatment  
Yes 
No 
 
45 (37) 
75 (63) 
 
Corticoids (prior to ICU admission)  
Yes 
No 
 
15 (12) 
105 (88) 
 
Opioids (prior to ICU admission) 
Yes 
No 
 
 
 
16 (13) 
104 (87) 
Benzodiazepines/antidepressants/anxiolytics (prior to ICU admission) 
Yes 
No 
 
 
24 (20) 
96 (80) 
Beta-blockers (prior to ICU admission) 
Yes 
No 
 
 
25 (21) 
95 (79) 
Variable Median (IQR) 
n=141 
Length of sedation and analgesia (hours) 
Propofol (n=116) 
Fentanyl (n=80) 
Midazolam (n=47) 
Morphine (n=26) 
Ketamine (n=8) 
 
Total doses of sedatives, analgesics and corticoids (milligrams)  
Propofol (n=119) 
Fentanyl (n=111) 
Midazolam (n=49) 
Morphine (n=37) 
Ketamine (n=8) 
Hydrocortisone (n=10) 
Oxycodone (n=38) 
Paracetamol (n=120) 
 
 
23 (7-83) 
46 (15-94) 
36 15-109) 
30 (15-85) 
40 (9-80) 
 
 
2960 (750-11290) 
4 (1-7) 
101 (17-218) 
48 (9-161) 
260 (36-350) 
450 (325-588) 
10 (5-65) 
7500 (4000-14750) 
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Table 3. Comparison between responders and non-responders at six months follow up (n=141) 
 Responders 
n=92 
Non-responders 
n=49 
p-value 
 
Mean (SD) 
 
Agea 56.8 (13.5) 49.0 (17.3) 0.008c 
 
Median (IQR) 
 
APACHE III scorea,b 56.0 (41.5-72.7) 62.0 (44.5-75.0) 0.569 
Length of ICU stay (days)a 4.0 (3.0-7.0) 5.0 (2.5-11.0) 0.219 
Length of Hospital stay (days)a 14.5 (9.3-25.8) 17.0 (9.2-29.0) 0.456 
FAS State Anxiety in ICUa,b 2.0 (1.2-3.0) 3.0 (1.7-3.5) 0.029c 
STAI Form –Y Trait anxietyb,d 35.0 (28.0-42.0)e 45.5 (34.5-51.5)e 0.001c 
 
Frequency (%) 
 
Gendera 
Male 
Female 
 
66 (72) 
26 (28) 
 
32 (65) 
17 (35) 
 
0.550 
a Calculated from baseline (ICU) data 
b APACHE: Acute Physiology and Chronic Health Evaluation System; STAI: State and Trait Anxiety Inventory; FAS: Faces Anxiety Scale; HADS: Hospital Anxiety Depression Scale 
c Significant ≤0.05 
d Calculated from assessment in the hospital wards (n=121)  
e  Responders=90 Non-responders=31 
T-test for normally distributed (age), Mann-Whitney test for not normally distributed (APACHE III score, length of ICU stay, Length of hospital stay, state anxiety in ICU, HADS-Anxiety and 
HADS-Depression) and Chi-Square test for categorical variables (gender).
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 Table 4. Linear Mixed Model: factors associated with symptoms of anxiety over six months after ICU discharge (n=120) 
Factors Coefficient (95% CI) p-value 
(Intercept) 2.90 (0.77, 5.01) 0.007 
Time 2 (3 months) -0.83 (-1.49, -0.16) 0.015 
Time 3 (6 months) -0.55 (-1.21, 0.10) 0.100 
Cognitive functioning (per 10 units) (score range 0-100) -0.41 (-0.64, -0.19) <0.0001 
Symptoms of depression (per unit) (score range 0-21) 0.37 (0.27, 0.48) <0.0001 
Trait anxiety  (per 10 units) (score range 20-80) 0.63 (0.20, 1.06) 0.004 
Post-traumatic stress symptoms at 6mo (per 10 units) (score range 10-70) 0.63 (0.30, 0.97) <0.0001 
Memories of experiencing anxiety during ICU stay 
No  
Yes  
  
Reference 
0.84 (0.17, 1.51) 
  
  
0.014 
Evidence of treatment for Mental health prior to ICU admission 
No  
Yes  
  
Reference 
-0.92 (-1.8, -0.09) 
  
  
0.029 
Akaike Information Criteria (AIC) for base model=1612, n=310; AIC for best model= 1235, n=264
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Table 5. Linear Mixed Model: factors associated with symptoms of depression over six months after ICU discharge (n=120) 
Factors Coefficient (95% CI) p-value 
(Intercept) 1.13 (-1.11, 3.38) 0.323 
Time 2 (3 months) -0.49 (-1.15, 0.16) 0.145 
Time 3 (6 months) -0.30 (-0.99, 0.37) 0.373 
Cognitive functioning (per 10 units) (score range 0-100) -0.46 (-0.68, -0.23) <0.0001 
Symptoms of anxiety (per unit) (score range 0-21) 0.43 (0.33, 0.54) <0.0001 
Trait anxiety (per 10 units) (score range 20-80) 0.75 (0.34, 1.15) <0.001 
Post-traumatic stress symptoms at 3mo (per 10 units) (score range 10-70) 0.54 (0.18, 0.89) 0.003 
Reason for ICU admission  
Medical 
Surgical (Incl. cardiac surgery) 
Trauma 
  
Reference 
-0.39 (-1.21, 0.41) 
1.72 (0.58, 2.85) 
  
  
0.337 
0.003 
Akaike Information Criteria (AIC) for base model=1612, n=310; AIC for best model= 1358, n=264
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 Supplementary material 1 
PATIENT DEMOGRAPHICS QUESTIONNAIRE 
 
Please answer the following questions about yourself by underlying the answer that corresponds 
to you: 
1. Marital status:  
Married          Never married          De facto          Separated          Divorced        Widowed 
 
2. Highest level of education completed: 
Primary school      
Secondary school (Grades 8, 9, 10) 
Secondary school (Grades 11, 12) 
Vocational/Apprenticeship/Trade Certificate 
Associate Diploma/Diploma  
Undergraduate Degree  
Postgraduate Degree  
Other (please list) ____________ 
 
3. Employment status before the ICU admission: 
In paid Full time work 
In paid Part time work 
In paid Casual work 
If in paid work, how many hours per 
week do you usually work? _______ 
Retired 
Student 
On Disability Benefit 
Unemployed 
Other (Please specify) __________ 
 
4. Have you ever visited a general practitioner (GP) or a mental health professional for 
symptoms of psychological distress or emotional problems? 
Yes                                    No 
 
5. Please record how often in the last 12 months you have smoked (please underline).   
Daily            Weekly            Less than weekly            Ex-smoker            Never-smoker 
 
39 
 
  
6. How many cigarettes (manufactured or roll-your own) did you used to smoke per day 
previous to the ICU stay?_____________
 
7. Where you taking any of the following medications before the ICU admission (12 
months?  
 
Corticosteroids replacement therapy (Hydrocortisone, prednisone, 
prednisolone) Other, please list ___________________ 
 
Opioids (e.g. morphine, MSContin, OxyContin, fentanyl, 
methadone, etc.). Other, please list_______________ 
 
Benzodiazepines, anxiolytics, antidepressant (e.g. diazepam, 
alprazolam, oxazepam). Other, please list__________________ 
 
Beta-blockers (e.g. propranolol, metoprolol). Other, please 
list_____________________ 
 
 
 
 
 
 
 
 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
 
 
 
 
 
 
 
 
 
No 
 
 
No 
 
 
No 
 
 
No
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 Supplementary material 2 
 
Supplementary material 2. Changes in the proportion of patients who presented with traumatic memories of the ICU admission across the three-
time point measurement. Participants who reported on Part A of the Post-traumatic Stress Symptoms 10-Question Inventory (PTSS-10) at all time points 
were included in this analysis (n=88). Participants with missing data on the Part A of the PTSS-10 at any time point measurement (n=32) were not included. 
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